GDC-0834 Racemate
CAS: 1133432-46-8
Ref. 3D-IVB43246
| 1mg | To inquire | |
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire |
Product Information
GDC-0834 is a new investigational drug that has been shown in animal studies to have anti-leukemic activity. GDC-0834 is an orally active, potent inhibitor of the enzyme aminopeptidase N (APN). It was found to be effective in inhibiting the growth of human leukemia cells in vitro and in vivo, and to reduce the number of circulating leukemic cells in humans with chronic lymphocytic leukemia. The mechanism by which GDC-0834 inhibits APN is not understood, but it may involve a nucleophilic attack on the amide group of the enzyme.
The following are some benefits of GDC-0834:
It is an orally active drug
It has potent anti-leukemia effects
It reduces circulating leukemic cells
It is effective against human leukemia cells in vitro and in vivo
It was found to be safe for use in humans
It can be
Chemical properties
Technical inquiry about: 3D-IVB43246 GDC-0834 Racemate
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
